Tirzepatide Pills vs Injection: What Exists in 2026
Tirzepatide pills vs injection is not a real choice yet: tirzepatide exists only as an injection. The US Zepbound and Mounjaro labels and the EU Mounjaro product information list only an injectable form. A ClinicalTrials.gov search for oral tirzepatide returned no oral study.
Other GLP-1 drugs do come as FDA-labeled tablets, including Foundayo (orforglipron) and oral semaglutide (Wegovy tablets for weight reduction, and Rybelsus and Ozempic tablets for type 2 diabetes), but none of them is tirzepatide. Anything sold as a tirzepatide tablet, drop or dissolving tablet is unapproved and untested in published human trials.
Short answer
- Is there an approved tirzepatide pill?
- No. Every US and EU tirzepatide label lists an injection only.
- Has one been tested?
- No oral tirzepatide trial was found on ClinicalTrials.gov or PubMed, so there is no data on whether one works.
- What is the GLP-1 pill?
- Orforglipron (Foundayo), a once-daily tablet and a different drug. Oral semaglutide is another GLP-1 pill: Wegovy tablets are FDA-labeled for weight reduction, and Rybelsus and Ozempic tablets for type 2 diabetes.
Sources: Zepbound FDA label; Mounjaro FDA label; EMA Mounjaro product information; Foundayo FDA label; Wegovy (semaglutide) FDA label; Rybelsus and Ozempic (semaglutide) tablets FDA label
What forms of tirzepatide the labels list
Every official tirzepatide record lists an injection and nothing else. The Zepbound label describes Zepbound as tirzepatide injection, for use under the skin. Its dosage form is a clear, colorless to slightly yellow solution. It comes in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens.
The Mounjaro label lists the same four injection presentations. The European Mounjaro product information gives its pharmaceutical form as solution for injection. A full-text search of the US labels found only injection presentations.
| Drug | Form | What the record says |
|---|---|---|
| Tirzepatide (Zepbound, Mounjaro) | Injection under the skin only | GIP and GLP-1 receptor agonist. No tablet on the US or EU labels, and no oral tirzepatide trial found |
| Orforglipron (Foundayo) | Tablet by mouth, once daily | A different drug: the label calls it a GLP-1 receptor agonist |
| Semaglutide | Tablet by mouth and injection | Both forms are FDA-labeled; Wegovy tablets are labeled for weight reduction, and the Rybelsus and Ozempic tablets for type 2 diabetes |
| "Oral tirzepatide" sold online | Tablets, drops or dissolving forms | Not in any FDA, EMA or trial record found; FDA says unapproved versions are not reviewed for safety, effectiveness and quality |
Sources: Zepbound FDA label; Mounjaro FDA label; EMA Mounjaro product information; Foundayo FDA label; Wegovy (semaglutide) FDA label; Rybelsus and Ozempic (semaglutide) tablets FDA label; FDA, concerns with unapproved GLP-1 drugs; Oral vs injected semaglutide model study, 2026
Do tirzepatide pills work?
No one knows, because none has been tested in people. Searches of ClinicalTrials.gov and PubMed for oral or under-the-tongue tirzepatide found no human trial, so there is no result to report.
Products sold as oral, sublingual or dissolving tirzepatide come from outside the approved supply. The FDA says some patients and health care professionals may look to unapproved versions of GLP-1 drugs for weight loss. It names semaglutide and tirzepatide.
It also says these unapproved versions do not undergo FDA review for safety, effectiveness and quality before they are marketed. No FDA, PubMed or trial record found addresses whether sublingual tirzepatide is safe or works. For how to spot fakes, see real vs fake GLP-1.
Is the tirzepatide shot better than the pill?
The shot is the only form with evidence behind it, so there is no pill to rank it against. The Zepbound label reports that about 80% of a dose injected under the skin reaches the bloodstream.
No study found measures how much tirzepatide reaches the blood from a tablet or a drop under the tongue. Without that, any claim that a tirzepatide pill matches the shot has no published data behind it.
Sources: Zepbound FDA label
Do GLP-1 pills work as well as injections?
For the drugs that do come as pills, the one broad comparison put them behind injected tirzepatide. A 2026 BMJ network meta-analysis compared each drug with lifestyle change alone, at one year.
| Drug | Form | Weight vs lifestyle alone |
|---|---|---|
| Tirzepatide | Injection | -14.9% |
| Oral semaglutide | Pill | -10.9% |
| Orforglipron | Pill | -9.9% |
| Subcutaneous semaglutide | Injection | -9.8% |
Semaglutide is the clearest pill-against-shot case because the same drug exists in both forms. A 2026 model-based analysis reported:
Oral semaglutide 25 mg gave estimated exposure and efficacy similar to subcutaneous semaglutide 2.4 mg
Disclaimer: these are study doses, not a recommendation. Dose decisions belong with a licensed clinician.
Orforglipron has its own trial data. The ATTAIN-1 trial in the New England Journal of Medicine ran for 72 weeks. Weight changed by -7.5%, -8.4% and -11.2% on the trial doses of 6 mg, 12 mg and 36 mg. Those are trial-paper doses, not the doses printed on the Foundayo label.
The ATTAIN-MAINTAIN trial took people who had already lost weight on tirzepatide (205 people) or semaglutide (171 people). It moved them to once-daily orforglipron or placebo. The full comparison is in orforglipron vs tirzepatide.
Sources: BMJ 2026 network meta-analysis; Oral vs injected semaglutide model study, 2026; ATTAIN-1, NEJM 2025; ATTAIN-MAINTAIN, 2026
How tirzepatide and the orforglipron pill are taken
The two differ in route and timing. Tirzepatide is a weekly shot, and the Foundayo tablet is taken every day. The Zepbound label says to give it once weekly, at any time of day, with or without meals. It goes under the skin of the abdomen or thigh. Another person can inject it in the back of the upper arm.
The Foundayo label says to take it by mouth once daily, with or without food. Tablets are swallowed whole, not broken, crushed or chewed. The FDA label for Foundayo lists:
Starting dose: 0.8 mg tablet once daily. After at least 30 days, 2.5 mg once daily. After at least 30 days more, 5.5 mg once daily. The dose can then rise, at least 30 days apart, to 9 mg, 14.5 mg or 17.2 mg, based on response and tolerability. Maximum: 17.2 mg once daily.
Disclaimer: this is label information, not a recommendation. Dose decisions belong with a licensed clinician.
The Foundayo label also warns that side effect rates from one drug's trials cannot be directly compared with another drug's. For the tirzepatide injection dose steps, see our tirzepatide dosage guide. The labeled Zepbound and Mounjaro vials hold a ready-to-use solution and are not mixed or reconstituted. A tirzepatide reconstitution calculator applies only to unapproved powder versions, which are not FDA-labeled products.
Sources: Zepbound FDA label; Foundayo FDA label
Tirzepatide pill and injection questions
Do tirzepatide pills work?+
There is no evidence either way, because no tirzepatide pill has been tested in a human trial. A ClinicalTrials.gov search for oral tirzepatide returned only injection studies, and the US Zepbound and Mounjaro labels and the EU Mounjaro product information list only an injection.
Is the tirzepatide shot better than the pill?+
There is nothing to compare: the shot is the only approved form of tirzepatide. Products sold as tirzepatide pills have no trial data. The FDA says unapproved GLP-1 versions, including tirzepatide, are not reviewed for safety, effectiveness and quality before they are marketed.
Do GLP-1 pills work as well as injections?+
It depends on the drug. In a 2026 BMJ network meta-analysis, weight change at one year compared with lifestyle change alone was -14.9% for injected tirzepatide, -10.9% for oral semaglutide, -9.9% for the orforglipron pill and -9.8% for injected semaglutide. These are indirect comparisons across different trials.
What is the most effective way to take tirzepatide?+
Tirzepatide has one approved route: a once-weekly injection under the skin. The Zepbound label says it can be given at any time of day, with or without meals, in the abdomen or thigh, or by another person in the back of the upper arm. About 80% of an injected dose reaches the blood.
Is orforglipron a tirzepatide pill?+
No. Orforglipron (sold as Foundayo) is a different drug. Its FDA label calls it a GLP-1 receptor agonist, while the Zepbound label calls tirzepatide a GIP receptor and GLP-1 receptor agonist. No trial has compared the two head to head.
Sources: Zepbound FDA label; Mounjaro FDA label; EMA Mounjaro product information; FDA, concerns with unapproved GLP-1 drugs; Foundayo FDA label; BMJ 2026 network meta-analysis
Related guides
This guide is for educational purposes only and is not medical advice. It describes what FDA and EMA records and published trials report about the forms of tirzepatide and oral GLP-1 drugs. Questions about your own medicine belong with a licensed clinician.